Replies to post #38 on JOURNAL REGISTER CO(NYSE: JRC) (JRC)

[drluck]

Additional risk factors are outlined in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

[hinchback]

what about the six months period?

April 3, 2008

Journal Register Company Notified by NYSE of Non-Compliance with a Continued Listing Standard

Yardley, PA – Journal Register Company (NYSE:JRC) today announced that on March 31, 2008 the Company was notified by the New York Stock Exchange that the Company had fallen below the NYSE’s continued listing standard relating to minimum share price. The NYSE standard requires that a company’s common stock trade at a minimum average closing price of $1.00 per share during a consecutive 30-day trading period.

Under the NYSE rules, the Company has ten business days to notify the NYSE of its intent to cure this deficiency and six months to cure it or be subject to suspension and delisting. The Company intends to notify the NYSE within the required ten business day period that it intends to cure the deficiency. Under the NYSE rules, the Company’s common stock will continue to be listed on the NYSE during the six month cure period, subject to compliance with the other NYSE continued listing requirements. Although the Company intends to cure its deficiency and to return to compliance with NYSE continued listing requirements, there can be no assurance that it will be able to do so.